pharma consulting companies

  USE The drug is used to treat certain types of cancer (such as chronic lymphocytic leukemia-CLL, follicular B-cell non-Hodgkin’s lymphoma, small lymphocytic lymphoma-SLL). Edarassib belongs to a class of drugs called kinase inhibitors. It works by slowing down or stopping the growth of cancer cells. How to use Zydelig See also the warning section. Please read the "Medication Guide" provided by your pharmacist before starting to take Atulixib and every time you supplement it. If you have any questions, please consult your doctor or pharmacist. Follow your doctor's instructions to take this medication by mouth, with or without food, usually twice a day. Swallow the entire tablet. Do not chew or crush the tablets. The dosage depends on your medical condition and response to treatment. Do not increase the dose, and do not use this medication more frequently or longer than prescribed. Your condition will not get better soon, and the risk of side effects will increase. Becaus...

 What is IDHIFA? how to use? IDHIFA is a prescription drug used to treat patients with acute myeloid leukemia (AML) with isocitrate dehydrogenase 2 (IDH2) mutations that have recovered or did not improve after previous treatment. It is not known whether IDHIFA is safe and effective in children. What are the possible side effects of IDHIFA? IDHIFA can cause serious side effects, including: See "What is the most important information I should know about IDHIFA?" The most common side effects of IDHIFA include: nausea Vomiting diarrhea jaundice Decreased appetite Tell your healthcare provider if there is any change in the color of your skin or whites of the eyes. Your healthcare provider will monitor your side effects during treatment, and if you experience certain side effects, they may tell you to stop taking IDHIFA. These are not all possible side effects of IDHIFA. description IDHIFA (Enanib) is an inhibitor of the isocitrate dehydrogenase 2 (IDH2) enzyme. Enasidenib is a met...

  What is Carbaglu? how to use? Carbaglu (carglumic acid) is an artificial form of liver enzyme used to treat hyperammonemia, which is a urea cycle disorder caused by a lack of certain liver enzymes. Carbaglu is usually used with other drugs to treat this lifelong disease. What are the side effects of Carbaglu? Common side effects of Carbaglu include: Vomiting diarrhea, stomachache, headache, Stuffy nose, sore throat, Ear infections Changes in taste, fever, infection, Flu symptoms lose weight, Lethargy, and rash description CARBAGLU tablets for oral suspension contain 200 mg of pyrophosphate. Active carbamic acid is the activator of carbamoyl phosphate synthase 1 (CPS 1), soluble in boiling water, slightly soluble in cold water, and almost insoluble in organic solvents. The chemical pyroic acid is N-carbamoyl-L-glutamic acid or (190) (2S)-2-(carbamoylamino)glutaric acid with a molecular weight of 190.16. The structural formula is: CARBAGLU® (pyrophosphoric acid)-structure diagram M...

  What is elaplase? Elaplase (idursulfase) is an intravenous infusion used to treat certain symptoms of genetic diseases, known as Hunter’s syndrome, also known as mucopolysaccharidosis (MYOO-koe-pol-ee- SAK-a-rye-DOE-sis). Isosulfite contains a natural enzyme that is lacking due to genetic diseases. Elaplase helps to replace this missing enzyme. Hunter syndrome is a metabolic disorder in which the body lacks the enzymes needed to break down certain sugars and proteins. These substances can accumulate in the body, causing organ enlargement, abnormal bone structure, changes in facial features, breathing problems, heart problems, decreased vision, and changes in mental or physical abilities. Elaplase can improve the walking ability of people in this situation. However, this drug cannot cure Hunter syndrome. warning Elaplase can improve the walking ability of patients with Hunter syndrome. However, elaplase cannot cure this condition. Some side effects may occur during or up to 24 hou...

 What is ZAVESCA? how to use? ZAVESCA is a prescription drug used only to treat adults with mild to moderate type 1 Gaucher disease. ZAVESCA is only for people who cannot receive enzyme replacement therapy. It is not clear whether ZAVESCA is safe and effective in children under 18 years of age. What are the possible side effects of ZAVESCA? ZAVESCA may cause serious side effects, including: Numbness, tingling, pain, or burning in the hands or feet (peripheral neuropathy). If you feel numbness, tingling, pain or burning in your hands and feet, call your healthcare provider immediately. Before you start ZAVESCA and during ZAVESCA treatment, your healthcare provider may test your nerves (neurological examination). New or worsening hand tremor (shaking). Tremors are common in ZAVESCA and may begin within the first month of starting treatment. Sometimes, if treatment is continued, the tremor may disappear within 1 to 3 months. If you experience new or worsening hand tremors, your health...

  What is CERDELGA? how to use? CERDELGA is a prescription drug used for the long-term treatment of adult Gaucher disease type 1 (GD1). Some people with Gaucher disease type 1 do not use CERDELGA. Your doctor will check to make sure that CERDELGA is right for you. It is not known whether CERDELGA is safe and effective in children. What are the possible side effects of CERDELGA? See "What is the most important information I should know about CERDELGA?" CERDELGA used with certain other drugs may cause changes in the electrical activity of the heart (ECG changes) and irregular heartbeats (arrhythmia). Tell the doctor if you have new symptoms, such as heart pits, fainting, or dizziness. The most common side effects of CERDELGA include: fatigue, headache, nausea, diarrhea and pain in the arms, legs, back or stomach (abdomen). Tell your doctor if you have any side effects that bother you or that will not go away. These are not all possible side effects of CERDELGA. Call your doctor...

  CYSTAGON (Cysteamine tartrate) capsules 50 mg and 150 mg description CYSTAGON® (cysteamine tartrate) capsules contain cysteamine tartrate, which is a cystine depleting agent that reduces the content of cystine in the cells of patients with cystinopathy, which is an inheritance of lysosomal transport defect. CYSTAGON® (cysteamine tartrate) is the hydrogen tartrate salt of cysteamine (an amino mercaptan, β-mercaptoethylamine). Cysteine ​​bitartrate is a highly water-soluble white powder with a molecular weight of 227 and a molecular formula of C2H7NS•C4H6O6. Has the following chemical structure: CYSTAGON® (cysteamine tartrate) structure diagram Each CYSTAGON® (cysteamine tartrate) capsule contains 50 mg or 150 mg of cysteamine free base, such as cysteamine tartrate. CYSTAGON® (cysteamine tartrate) capsules contain the following inactive ingredients: colloidal silica, croscarmellose sodium, D&C yellow. 10 aluminum color lake water, FD&C blue. 1 aluminum lake, FD&C blue. ...